Cipla’s Revlimid Settlement Offers Date-Certain US Launch

Deal With Bristol Myers Squibb's Celgene Allows Initial ‘Limited’ Volumes

 
• By David Wallace
Handshake
Cipla and Bristol Myers Squibb's Celgene have settled over Revlimid • Source: Shutterstock

More from Deals

More from Business